As of 2026-09-14, the Fair Value of Keros Therapeutics Inc (KROS) is -21.01 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 11.08 USD, the upside of Keros Therapeutics Inc is -289.62%.
With the market price of 11.08 USD and our fair value calculation, Keros Therapeutics Inc (KROS) is not a good investment. Investing in KROS stocks now will result in a potential loss of 289.62%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -58.74 | -104.68 | -152.99 | -187.35 | 87.01 | -83.35 |
| YoY growth | -29.50% | -78.21% | -46.15% | -22.46% | 146.44% | -5.97% |
| Market Cap (mil) | 219.27 |
| P/E | |
| Forward P/E | 1,536.08x |
| EPS | -4.20 |
| Avg earnings growth rate | -5.97% |
| TTM earnings | -83.16 |